Biosimilar Development is dedicated to presenting technical information, thought leadership, and commentary for the biosimilar development and manufacturing community. Users will find exclusive and actionable content on the industry trends and challenges affecting the emerging biosimilars market. Biosimilar Development is part of Life Science Connect at VertMarkets. Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.
| Website | https://www.biosimilardevelopment.com/ |
| Revenue | $6.8 million |
| Employees | View employees |
| Address | 5340 Fryling Rd. Suite 300, Erie, Pennsylvania 16510, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+25 more
(view full list)
|
| Industry | Book and Periodical Publishing |
| Competitors | Roche, Pfizer, Samsung Bioepis, GSK, Amgen, Teva Pharmaceuticals, Sandoz, Eisai Co., Ltd., Biocon, Mylan Belgium +39 more (view full list) |
Looking for a particular Biosimilar Development employee's phone or email?
Biosimilar Development Questions
The Biosimilar Development annual revenue was $6.8 million in 2026.
Biosimilar Development is based in Erie, Pennsylvania.
Related Companies
